Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

BACKGROUND: To compare the efficacy of 12-month denosumab treatment on bone mineral density (BMD) and bone turnover markers (BTMs) between treatment-naïve osteoporosis patients with rheumatoid arthritis (RA) and those with previous bisphosphonate (BP) therapy. METHODS: A total of 36 RA patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Orthop
Autors principals: Kaneko, Tetsuya, Okamura, Koichi, Yonemoto, Yukio, Okura, Chisa, Suto, Takahito, Tachibana, Masahiro, Sakane, Hideo, Inoue, Makoto, Chikuda, Hirotaka
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6820644/
https://ncbi.nlm.nih.gov/pubmed/31664591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40634-019-0211-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars